Sequential changes in the non-coding control region sequences of JC polyomaviruses from the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

Archives of Virology

Volumn 158, Issue 3, 2013, Pages 639-650

  Nakamichi, Kazuo ^a   Kishida, Shuji ^b   Tanaka, Kozue ^b   Suganuma, Akihiko ^b   Sano, Yasuteru ^c   Sano, Hironori ^c   Kanda, Takashi ^c   Maeda, Norihisa ^d   Kira, Jun ichi ^d   Itoh, Ai ^e   Kato, Natsuko ^e   Tomimoto, Hidekazu ^e   Kurane, Ichiro ^a   Lim, Chang Kweng ^a   Mizusawa, Hidehiro ^f   Saijo, Masayuki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e MIE UNIVERSITY   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

JC POLYOMAVIRUS; POLYOMAVIRUS;

EID: 84874654606     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1532-3     Document Type: Article

References (58)

1. White MK, Safak M, Khalili K (2009) Regulation of gene expression in primate polyomaviruses. J Virol 83: 10846-10856. doi: 10. 1128/JVI. 00542-09.
2. Brew BJ, Davies NW, Cinque P, Clifford DB, Nath A (2010) Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol 6: 667-679. doi: 10. 1038/nrneurol. 2010. 164.
3. Marshall LJ, Major EO (2010) Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy. J Neuroimmune Pharmacol 5: 404-417.
4. Tan CS, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9: 425-437.
5. Shishido-Hara Y (2010) Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease. Acta Neuropathol 120: 403-417. doi: 10. 1007/s00401-010-0694-x.
6. Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH (2009) Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 48: 1459-1466. doi: 10. 1086/598335.
7. Major EO (2010) Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61: 35-47. doi: 10. 1146/annurev. med. 080708. 082655.
8. Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel RP, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ (2009) Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med 361: 1067-1074.
9. Jensen PN, Major EO (2001) A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J Neurovirol 7: 280-287. doi: 10. 1080/13550280152537102.
10. Marshall LJ, Dunham L, Major EO (2010) Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. J Gen Virol 91: 3042-3052. doi: 10. 1099/vir. 0. 023184-0.
11. Imperiale MJ, Major EO (2007) Polyomaviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds) Fields virology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2263-2298.
12. Frisque RJ (1983) Regulatory sequences and virus-cell interactions of JC virus. Prog Clin Biol Res 105: 41-59.
13. Frisque RJ, Bream GL, Cannella MT (1984) Human polyomavirus JC virus genome. J Virol 51: 458-469.
14. Yogo Y, Kitamura T, Sugimoto C, Ueki T, Aso Y, Hara K, Taguchi F (1990) Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol 64: 3139-3143.
15. Tan CS, Ellis LC, Wuthrich C, Ngo L, Broge TA Jr, Saint-Aubyn J, Miller JS, Koralnik IJ (2010) JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J Virol 84: 9200-9209. doi: 10. 1128/JVI. 00609-10.
16. Seth P, Diaz F, Major EO (2003) Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy. J Neurovirol 9: 236-246.
17. Ault GS, Stoner GL (1993) Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. J Gen Virol 74: 1499-1507.
18. Yogo Y, Sugimoto C (2001) The archetype concept and regulatory region rearrangement. In: Khalili K, Stoner GL (eds) Human polyomaviruses: molecular and clinical perspectives. Wiley-Liss, New York, pp 127-148.
19. Gosert R, Kardas P, Major EO, Hirsch HH (2010) Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate. J Virol 84: 10448-10456. doi: 10. 1128/JVI. 00614-10.
20. Martin JD, Li P (1991) Enhancer/promoter activities of regulatory regions of representative JC virus isolates. Arch Virol 120: 305-311. doi: 10. 1007/BF01310486.
21. Agostini HT, Ryschkewitsch CF, Singer EJ, Stoner GL (1997) JC virus regulatory region rearrangements and genotypes in progressive multifocal leukoencephalopathy: two independent aspects of virus variation. J Gen Virol 78: 659-664.
22. Ciappi S, Azzi A, De Santis R, Leoncini F, Sterrantino G, Mazzotta F, Mecocci L (1999) Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. J Gen Virol 80: 1017-1023.
23. Iida T, Kitamura T, Guo J, Taguchi F, Aso Y, Nagashima K, Yogo Y (1993) Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 90: 5062-5065.
24. Martin JD, King DM, Slauch JM, Frisque RJ (1985) Differences in regulatory sequences of naturally occurring JC virus variants. J Virol 53: 306-311.
25. Marzocchetti A, Wuthrich C, Tan CS, Tompkins T, Bernal-Cano F, Bhargava P, Ropper AH, Koralnik IJ (2008) Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirol 14: 455-458. doi: 10. 1080/13550280802356837.
26. Newman JT, Frisque RJ (1997) Detection of archetype and rearranged variants of JC virus in multiple tissues from a pediatric PML patient. J Med Virol 52: 243-252. doi: 10. 1002/(SICI)1096-9071(199707)52: 3< 243: AID-JMV2> 3. 0. CO; 2-2.
27. Reid CE, Li H, Sur G, Carmillo P, Bushnell S, Tizard R, McAuliffe M, Tonkin C, Simon K, Goelz S, Cinque P, Gorelik L, Carulli JP (2011) Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients. J Infect Dis 204: 237-244. doi: 10. 1093/infdis/jir256.
28. Roux D, Bouldouyre MA, Mercier-Delarue S, Seilhean D, Zagdanski AM, Delaugerre C, Simon F, Molina JM, Legoff J (2011) JC virus variant associated with cerebellar atrophy in a patient with AIDS. J Clin Microbiol 49: 2196-2199. doi: 10. 1128/JCM. 02057-10.
29. Sugimoto C, Ito D, Tanaka K, Matsuda H, Saito H, Sakai H, Fujihara K, Itoyama Y, Yamada T, Kira J, Matsumoto R, Mori M, Nagashima K, Yogo Y (1998) Amplification of JC virus regulatory DNA sequences from cerebrospinal fluid: diagnostic value for progressive multifocal leukoencephalopathy. Arch Virol 143: 249-262.
30. Tan CS, Dezube BJ, Bhargava P, Autissier P, Wuthrich C, Miller J, Koralnik IJ (2009) Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis 199: 881-888. doi: 10. 1086/597117.
31. Yasuda Y, Yabe H, Inoue H, Shimizu T, Yabe M, Yogo Y, Kato S (2003) Comparison of PCR-amplified JC virus control region sequences from multiple brain regions in PML. Neurology 61: 1617-1619. doi: 10. 1212/01. WNL. 0000096147. 47128. 7D.
32. Yogo Y, Guo J, Iida T, Satoh K, Taguchi F, Takahashi H, Hall WW, Nagashima K (1994) Occurrence of multiple JC virus variants with distinctive regulatory sequences in the brain of a single patient with progressive multifocal leukoencephalopathy. Virus Genes 8: 99-105.
33. Delbue S, Elia F, Carloni C, Tavazzi E, Marchioni E, Carluccio S, Signorini L, Novati S, Maserati R, Ferrante P (2012) JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy. J Cell Physiol 227: 3511-3517. doi: 10. 1002/jcp. 24051.
34. O'Neill FJ, Greenlee JE, Dorries K, Clawson SA, Carney H (2003) Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus. J Neurovirol 9: 567-576.
35. Ravichandran V, Major EO (2008) DNA-binding transcription factor NF-1A negatively regulates JC virus multiplication. J Gen Virol 89: 1396-1401. doi: 10. 1099/vir. 0. 2008/000059-0.
36. Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D, Mena M, Gerevini S, Bestetti A, Pedale R, Sala S, Sala S, Lazzarin A, Cinque P (2005) Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 40: 738-744. doi: 10. 1086/427698.
37. Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K, Frisque RJ, Gorelik L (2009) Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53: 1840-1849. doi: 10. 1128/AAC. 01614-08.
38. Gofton TE, Al-Khotani A, O'Farrell B, Ang LC, McLachlan RS (2011) Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 82: 452-455. doi: 10. 1136/jnnp. 2009. 190652.
39. Kishida S, Tanaka K (2010) Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. Intern Med 49: 2509-2513. doi: org/10. 2169/internalmedicine. 49. 3227.
40. Schröder A, Lee DH, Hellwig K, Lukas C, Linker RA, Gold R (2010) Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol 67: 1391-1394. doi: 10. 1001/archneurol. 2010. 157.
41. Nakamichi K, Kurane I, Saijo M (2011) Evaluation of a quantitative real-time PCR assay for the detection of JC polyomavirus DNA in cerebrospinal fluid without nucleic acid extraction. Jpn J Infect Dis 64: 211-216.
42. Howley PM, Rentier-Delrue F, Heilman CA, Law MF, Chowdhury K, Israel MA, Takemoto KK (1980) Cloned human polyomavirus JC DNA can transform human amnion cells. J Virol 36: 878-882.
43. Agostini HT, Ryschkewitsch CF, Baumhefner RW, Tourtellotte WW, Singer EJ, Komoly S, Stoner GL (2000) Influence of JC virus coding region genotype on risk of multiple sclerosis and progressive multifocal leukoencephalopathy. J Neurovirol 6(Suppl 2): S101-S108.
44. Agostini HT, Ryschkewitsch CF, Stoner GL (1996) Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol 34: 159-164.
45. Dubois V, Moret H, Lafon ME, Brodard V, Icart J, Ruffault A, Guist'hau O, Buffet-Janvresse C, Abbed K, Dussaix E, Ingrand D (2001) JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy. J Infect Dis 183: 213-217. doi: 10. 1086/317927.
46. Loeber G, Dorries K (1988) DNA rearrangements in organ-specific variants of polyomavirus JC strain GS. J Virol 62: 1730-1735.
47. Sala M, Vartanian JP, Kousignian P, Delfraissy JF, Taoufik Y, Wain-Hobson S, Gasnault J (2001) Progressive multifocal leukoencephalopathy in human immunodeficiency virus type 1-infected patients: absence of correlation between JC virus neurovirulence and polymorphisms in the transcriptional control region and the major capsid protein loci. J Gen Virol 82: 899-907.
48. Zheng HY, Yasuda Y, Kato S, Kitamura T, Yogo Y (2004) Stability of JC virus coding sequences in a case of progressive multifocal leukoencephalopathy in which the viral control region was rearranged markedly. Arch Pathol Lab Med 128: 275-278.
49. Kuhle J, Gosert R, Buhler R, Derfuss T, Sutter R, Yaldizli O, Radue EW, Ryschkewitsch C, Major EO, Kappos L, Frank S, Hirsch HH (2011) Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology 77: 2010-2016. doi: 10. 1212/WNL. 0b013e31823b9b27.
50. Chowdhury M, Taylor JP, Tada H, Rappaport J, Wong-Staal F, Amini S, Khalili K (1990) Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. Oncogene 5: 1737-1742.
51. Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K (1990) Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 87: 3479-3483.
52. Gosert R, Rinaldo CH, Funk GA, Egli A, Ramos E, Drachenberg CB, Hirsch HH (2008) Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 205: 841-852. doi: 10. 1084/jem. 20072097.
53. Marshall LJ, Moore LD, Mirsky MM, Major EO (2012) JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes. J Gen Virol 93: 651-661. doi: 10. 1099/vir. 0. 035832-0.
54. Jones R, Kunsman G, Levine B, Smith M, Stahl C (1994) Mefloquine distribution in postmortem cases. Forensic Sci Int 68: 29-32. doi: org/10. 1016/0379-0738(94)90376-X.
55. Pham YT, Nosten F, Farinotti R, White NJ, Gimenez F (1999) Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int J Clin Pharmacol Ther 37: 58-61.
56. Beppu M, Kawamoto M, Nukuzuma S, Kohara N (2012) Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med 51: 1245-1247. doi: org/10. 2169/internalmedicine. 51. 6810.
57. Hirayama M, Nosaki Y, Matsui K, Terao S, Kuwayama M, Tateyama H, Yoshida M, Hashizume Y (2012) Efficacy of mefloquine to progressive multifocal leukoencephalopathy initially presented with parkinsonism. Clin Neurol Neurosurg 114: 728-731. doi: org/10. 1016/j. clineuro. 2011. 12. 010.
58. Naito K, Ueno H, Sekine M, Kanemitsu M, Ohshita T, Nakamura T, Yamawaki T, Matsumoto M (2012) Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI study. Intern Med 51: 205-209. doi: org/10. 2169/internalmedicine. 51. 6253.